MTOR and prostate carcinoma: Therefore, our R26MTA1; Ptenf/f mice mimic a subtype of advanced prostate cancer that exhibits the involvement of mTOR signaling, suggesting that targeting the MTA1/mTOR pathway by natural stilbene gnetin C could be an effective means for blocking prostate cancer progression.